ArticleSurgical endoscopy2026
A novel bile leak test using contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a prospective single-arm trial.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBile leak (BL) remains a major complication after liver resection and is associated with substantial postoperative morbidity. Conventional dye-based tests can identify visible leakage from the transection surface, but whether the injected reagent has adequately reached peripheral intrahepatic ducts adjacent to the cut surface is often uncertain. We evaluated the feasibility and safety of a novel BL test using contrast-enhanced intraoperative ultrasonic cholangiography (CE-IOUSC) for real-time confirmation of intrabiliary reagent filling.
methodsThis prospective single-arm trial included 29 patients undergoing open liver resection under the finalized protocol between March 2021 and February 2024. A reagent consisting of diluted Sonazoid, indigo carmine, and saline was injected through a cystic-duct catheter while the distal common bile duct was clamped. Ductal filling near the transection plane was assessed using contrast harmonic ultrasonography during and immediately after manual divided injection. Outcomes included technical success, postoperative BL, injection-related adverse events, and exploratory comparison of postoperative liver enzymes with a historical conventional-test cohort.
resultsCE-IOUSC testing was technically successful in 25 of 29 patients (86.2%). The median total injected volume was 5 mL (range 2-22 mL), and the median number of divided injections was 2 (range 1-6). Intraoperative BL was detected and sutured in 3 patients. Postoperative BL occurred in 5 patients (17.2%): 4 after technical success and 1 after technical failure. No adverse events related to intrabiliary reagent injection were observed. Postoperative AST and ALT elevations were significantly lower than in the historical cohort, although this comparison was exploratory.
conclusionsCE-IOUSC-based BL testing was feasible and safe in open liver resection and enabled real-time confirmation of intrabiliary reagent filling near the transection surface. Its clinical efficacy in reducing postoperative BL or liver injury remains unproven and should be evaluated in future comparative studies.
Indexed as
Identifiers
42420496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.